---
schema_version: "secwatch.filing_event.v1"
accession: "0001534969-23-000050"
form_type: "8-K"
ticker: "SERA"
cik: "0001534969"
company_name: "SERA PROGNOSTICS, INC."
filed_at: "2023-05-10T23:59:59+00:00"
generated_at: "2026-06-15T06:18:08.753155+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Sera Prognostics Q1 revenue $100K, net loss $10.6M; AVERT trial positive

## Summary
- Revenue $100K, up 163% from $38K in Q1 2022.
- Net loss narrowed to $10.6M from $12.2M YoY.
- Cash and securities $100M; R&D spend $4.1M (up), SG&A $7.3M (down).
- Positive AVERT PRETERM TRIAL topline results announced in February.
- Physician orders increasing; PRIME study interim look expected by year-end.

## SEC filing metadata
- accession: 0001534969-23-000050
- form_type: 8-K
- ticker: SERA
- cik: 0001534969
- company_name: SERA PROGNOSTICS, INC.
- filed_at: 2023-05-10T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1534969/000153496923000050/0001534969-23-000050-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1534969/000153496923000050/sera-20230510.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001534969-23-000050
- JSON: https://secwatch.observer/filing/0001534969-23-000050.json
- Plain text: https://secwatch.observer/filing/0001534969-23-000050.txt

## Key facts
- Earnings Releases
  SERA PROGNOSTICS, INC. reported the first quarter of 2023 ended March 31, 2023 results: revenue $100,000, net income $10.6 million loss.
  - Period: the first quarter of 2023 ended March 31, 2023
  - Revenue: $100,000
  - Net income: $10.6 million loss
  - Result: reported results
  source text: should serve as an additional catalyst to help us expand the use of our PreTRM Test and to increase revenue.” First Quarter 2023 Financial Results First quarter 2023 revenue of $100,000 compared to $38,000 for the same period of 2022. Total operating expenses were $11.4 million, down from $12.3 million for the first quarter of 2022. Research and development
  evidence_url: https://www.sec.gov/Archives/edgar/data/1534969/000153496923000050/0001534969-23-000050-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.